On p. 1123 of the November 2000 issue, the commentary entitled “Good faith gone bad” by Harvey Bialy contains the sentence “Their collaboration continued, during which time Alagon discovered that the bat protein had a specificity for fibrin that was many times greater than other commercially produced tissue plasminogen activators (tPAs).” This is inaccurate in that, at the time, commercial production of tPAs was still a few years away.
Additional information
The online version of the original article can be found at 10.1038/81027
Rights and permissions
About this article
Cite this article
Erratum: “Good faith gone bad“ . Nat Biotechnol 19, 912 (2001). https://doi.org/10.1038/nbt1001-912b
Issue Date:
DOI: https://doi.org/10.1038/nbt1001-912b